あすか製薬ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/04/22 | 2,240 | 2,240 | 2,207 | 2,222 | +15 | +0.7% | 22,100 |
| 2024/04/19 | 2,244 | 2,244 | 2,164 | 2,207 | -45 | -2% | 85,500 |
| 2024/04/18 | 2,220 | 2,273 | 2,203 | 2,252 | +53 | +2.4% | 40,000 |
| 2024/04/17 | 2,275 | 2,275 | 2,163 | 2,199 | -64 | -2.8% | 59,300 |
| 2024/04/16 | 2,283 | 2,313 | 2,249 | 2,263 | -22 | -1% | 64,000 |
| 2024/04/15 | 2,250 | 2,292 | 2,223 | 2,285 | +25 | +1.1% | 52,400 |
| 2024/04/12 | 2,210 | 2,281 | 2,208 | 2,260 | +67 | +3.1% | 85,600 |
| 2024/04/11 | 2,177 | 2,197 | 2,174 | 2,193 | -7 | -0.3% | 43,600 |
| 2024/04/10 | 2,166 | 2,201 | 2,165 | 2,200 | +42 | +1.9% | 29,300 |
| 2024/04/09 | 2,198 | 2,201 | 2,145 | 2,158 | -24 | -1.1% | 48,400 |
| 2024/04/08 | 2,199 | 2,199 | 2,160 | 2,182 | -30 | -1.4% | 77,000 |
| 2024/04/05 | 2,174 | 2,219 | 2,174 | 2,212 | +41 | +1.9% | 45,500 |
| 2024/04/04 | 2,172 | 2,183 | 2,159 | 2,171 | +1 | ±0% | 56,000 |
| 2024/04/03 | 2,194 | 2,194 | 2,145 | 2,170 | -24 | -1.1% | 82,200 |
| 2024/04/02 | 2,193 | 2,229 | 2,177 | 2,194 | +34 | +1.6% | 101,500 |
| 2024/04/01 | 2,200 | 2,207 | 2,150 | 2,160 | -59 | -2.7% | 71,600 |
| 2024/03/29 | 2,202 | 2,244 | 2,195 | 2,219 | +9 | +0.4% | 42,900 |
| 2024/03/28 | 2,223 | 2,227 | 2,191 | 2,210 | -33 | -1.5% | 42,200 |
| 2024/03/27 | 2,231 | 2,259 | 2,219 | 2,243 | +13 | +0.6% | 84,700 |
| 2024/03/26 | 2,149 | 2,233 | 2,145 | 2,230 | +105 | +4.9% | 89,000 |
| 2024/03/25 | 2,120 | 2,142 | 2,112 | 2,125 | ±0 | ±0% | 35,500 |
| 2024/03/22 | 2,144 | 2,147 | 2,120 | 2,125 | -19 | -0.9% | 28,800 |
| 2024/03/21 | 2,137 | 2,158 | 2,130 | 2,144 | +2 | +0.1% | 33,000 |
| 2024/03/19 | 2,125 | 2,149 | 2,113 | 2,142 | +25 | +1.2% | 31,000 |
| 2024/03/18 | 2,144 | 2,155 | 2,110 | 2,117 | -3 | -0.1% | 80,700 |
| 2024/03/15 | 2,107 | 2,134 | 2,091 | 2,120 | +16 | +0.8% | 56,200 |
| 2024/03/14 | 2,142 | 2,158 | 2,090 | 2,104 | -38 | -1.8% | 66,800 |
| 2024/03/13 | 2,150 | 2,182 | 2,115 | 2,142 | +3 | +0.1% | 65,700 |
| 2024/03/12 | 2,146 | 2,147 | 2,114 | 2,139 | +21 | +1% | 60,600 |
| 2024/03/11 | 2,081 | 2,118 | 2,081 | 2,118 | -25 | -1.2% | 75,000 |
| 2024/03/08 | 2,062 | 2,150 | 2,062 | 2,143 | +67 | +3.2% | 74,200 |
| 2024/03/07 | 2,039 | 2,085 | 2,039 | 2,076 | +47 | +2.3% | 70,900 |
| 2024/03/06 | 2,000 | 2,035 | 1,999 | 2,029 | +27 | +1.3% | 64,600 |
| 2024/03/05 | 2,028 | 2,031 | 2,002 | 2,002 | -19 | -0.9% | 51,600 |
| 2024/03/04 | 2,031 | 2,038 | 1,988 | 2,021 | -29 | -1.4% | 77,300 |
| 2024/03/01 | 2,082 | 2,094 | 2,029 | 2,050 | -37 | -1.8% | 71,800 |
| 2024/02/29 | 2,099 | 2,105 | 2,061 | 2,087 | -14 | -0.7% | 79,900 |
| 2024/02/28 | 2,079 | 2,108 | 2,060 | 2,101 | +62 | +3% | 74,600 |
| 2024/02/27 | 2,058 | 2,071 | 2,033 | 2,039 | -19 | -0.9% | 52,500 |
| 2024/02/26 | 2,058 | 2,094 | 2,040 | 2,058 | ±0 | ±0% | 53,500 |
| 2024/02/22 | 2,103 | 2,103 | 2,056 | 2,058 | -6 | -0.3% | 58,800 |
| 2024/02/21 | 2,100 | 2,111 | 2,055 | 2,064 | +13 | +0.6% | 75,000 |
| 2024/02/20 | 2,040 | 2,071 | 2,024 | 2,051 | +6 | +0.3% | 68,900 |
| 2024/02/19 | 1,950 | 2,048 | 1,950 | 2,045 | +83 | +4.2% | 106,500 |
| 2024/02/16 | 1,940 | 1,970 | 1,940 | 1,962 | +30 | +1.6% | 56,300 |
| 2024/02/15 | 1,960 | 1,960 | 1,917 | 1,932 | -20 | -1% | 66,000 |
| 2024/02/14 | 1,955 | 1,959 | 1,946 | 1,952 | -3 | -0.2% | 43,900 |
| 2024/02/13 | 1,977 | 1,977 | 1,945 | 1,955 | +5 | +0.3% | 77,500 |
| 2024/02/09 | 1,950 | 1,958 | 1,937 | 1,950 | +19 | +1% | 89,500 |
| 2024/02/08 | 1,905 | 1,946 | 1,896 | 1,931 | +29 | +1.5% | 91,500 |
251～
300
件表示中 / 999件
類似銘柄と比較する
現在ご覧いただいている「あすかＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| あすかＨＤ | 229,700円 | +0.3% | +2.7% | 2.18% | 13.03倍 | 1.02倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
| 栄研化 | 223,500円 | +0.4% | -8.4% | 2.37% | 28.69倍 | 1.62倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| ネクセラファーマ | 93,400円 | +22.8% | - | 0.00% | 76.31倍 | 1.22倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ＪＣＲファーマ | 49,600円 | -23.0% | - | 4.03% | - | 1.07倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| ハートシード | 249,900円 | +174.2% | - | 0.00% | - | 8.51倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
市場注目の銘柄
チャート関連のコラム
